WALTHAM, Mass.--Genome Therapeutics here has licensed its proprietary microbial sequence database, PathoGenome, to Hoechst Marion Roussel. The pharmaceutical company will use the database to develop antiinfective products. Hoechst will pay annual subscription fees and royalties for nonexclusive access to the database. PathoGenome contains genomic sequence information from 24 microbial organisms assembled through Genome Therapeutics' pathogen genomics research and public-domain sources, as well as in-depth sequence analysis and proprietary bioinformatics tools.
Hoechst Marion Roussel Licenses Database from Genome Therapeutics
Nov 21, 1998